Browse by UCL people
Group by: Type | Date
Number of items: 210.
Article
Abbosh, C;
Hodgson, D;
Doherty, GJ;
Gale, D;
Black, JRM;
Horn, L;
Reis-Filho, JS;
(2024)
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer.
Trends in Cancer
, 10
(7)
pp. 643-654.
10.1016/j.trecan.2024.04.004.
|
Abbosh, C;
Swanton, C;
(2021)
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
PLoS Medicine
, 18
(10)
, Article e1003771. 10.1371/journal.pmed.1003771.
|
Abbosh, Christopher;
Frankell, Alexander M;
Harrison, Thomas;
Kisistok, Judit;
Garnett, Aaron;
Johnson, Laura;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2023)
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Nature
, 616
(7957)
pp. 553-562.
10.1038/s41586-023-05776-4.
|
Abbosh, C;
Birkbak, NJ;
Wilson, GA;
Jamal-Hanjani, M;
Constantin, T;
Salari, R;
Le Quesne, J;
... Dessimoz, C; + view all
(2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
, 545
pp. 446-451.
10.1038/nature22364.
|
Abbosh, C;
Swanton, C;
Birkbak, NJ;
(2018)
Circulating tumor DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.
Annals of Oncology
10.1093/annonc/mdy017.
(In press).
|
Abbosh, C;
Venkatesan, S;
Janes, SM;
Fitzgerald, RC;
Swanton, C;
(2017)
Evolutionary dynamics in pre-invasive neoplasia.
Current Opinion in System Biology
, 2
pp. 1-8.
10.1016/j.coisb.2017.02.009.
|
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
Aitken, J;
Ambrose, K;
Barrell, S;
Beale, R;
Bineva-Todd, G;
Biswas, D;
Byrne, R;
... Wu, M; + view all
(2020)
Scalable and robust SARS-CoV-2 testing in an academic center.
Nature Biotechnology
, 38
(8)
pp. 927-931.
10.1038/s41587-020-0588-y.
|
Al Bakir, Maise;
Huebner, Ariana;
Martínez-Ruiz, Carlos;
Grigoriadis, Kristiana;
Watkins, Thomas BK;
Pich, Oriol;
Moore, David A;
... Swanton, Charles; + view all
(2023)
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature
10.1038/s41586-023-05729-x.
(In press).
|
Alwan, NA;
Burgess, RA;
Ashworth, S;
Beale, R;
Bhadelia, N;
Bogaert, D;
Dowd, J;
... Ziauddeen, H; + view all
(2020)
Scientific consensus on the COVID-19 pandemic: we need to act now.
The Lancet
, 396
(10260)
e71-e72.
10.1016/S0140-6736(20)32153-X.
|
Au, L;
Fendler, A;
Shepherd, STC;
Rzeniewicz, K;
Cerrone, M;
Byrne, F;
Carlyle, E;
... Turajlic, S; + view all
(2021)
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Nature Medicine
10.1038/s41591-021-01387-6.
|
Bailey, C;
Black, JRM;
Reading, JL;
Litchfield, K;
Turajlic, S;
McGranahan, N;
Jamal-Hanjani, M;
(2021)
Tracking Cancer Evolution through the Disease Course.
Cancer Discovery
, 11
(4)
pp. 916-932.
10.1158/2159-8290.CD-20-1559.
|
Bailey, Chris;
Pich, Oriol;
Thol, Kerstin;
Watkins, Thomas BK;
Luebeck, Jens;
Rowan, Andrew;
Stavrou, Georgia;
... Swanton, Charles; + view all
(2024)
Origins and impact of extrachromosomal DNA.
Nature
, 635
(8037)
pp. 193-200.
10.1038/s41586-024-08107-3.
|
Bailey, C;
Black, JRM;
Swanton, C;
(2020)
Cancer Research: The Lessons to Learn from COVID-19.
Cancer Discovery
, 10
(9)
pp. 1263-1266.
10.1158/2159-8290.CD-20-0823.
|
Bailey, C;
Shoura, MJ;
Mischel, PS;
Swanton, C;
(2020)
Extrachromosomal DNA d relieving heredity constraints, accelerating tumour evolution.
Annals of Oncology
, 31
(7)
pp. 884-893.
10.1016/j.annonc.2020.03.303.
|
Bakhoum, SF;
Ngo, B;
Laughney, AM;
Cavallo, J-A;
Murphy, CJ;
Ly, P;
Shah, P;
... Cantley, LC; + view all
(2018)
Chromosomal instability drives metastasis through a cytosolic DNA response.
Nature
, 553
(7689)
pp. 467-472.
10.1038/nature25432.
|
Balestrini, S;
Koepp, MJ;
Gandhi, S;
Rickman, HM;
Yen Shin, G;
Houlihan, CF;
Anders-Cannon, J;
... Sisodiya, SM; + view all
(2021)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
Epilepsy & Behavior
, 115
, Article 107602. 10.1016/j.yebeh.2020.107602.
|
Barbieri, CE;
Chinnaiyan, AM;
Lerner, SP;
Swanton, C;
Rubin, MA;
(2017)
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
European Urology
, 71
(2)
pp. 237-246.
10.1016/j.eururo.2016.08.024.
|
Barrett, JE;
Feber, A;
Herrero, J;
Tanic, M;
Wilson, GA;
Swanton, C;
Beck, S;
(2017)
Quantification of tumour evolution and heterogeneity via Bayesian epiallele detection.
BMC Bioinformatics
, 18
, Article 354. 10.1186/s12859-017-1753-2.
|
Bentham, R;
Litchfield, K;
Watkins, TBK;
Lim, EL;
Rosenthal, R;
Martinez-Ruiz, C;
Hiley, CT;
... McGranahan, N; + view all
(2021)
Using DNA sequencing data to quantify T cell fraction and therapy response.
Nature
, 597
pp. 555-560.
10.1038/s41586-021-03894-5.
|
Bentzen, AK;
Marquard, AM;
Lyngaa, R;
Saini, SK;
Ramskov, S;
Donia, M;
Such, L;
... Hadrup, SR; + view all
(2016)
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Nature Biotechnology
, 34
(10)
pp. 1037-1045.
10.1038/nbt.3662.
|
Berenjeno, IM;
Piñeiro, R;
Castillo, SD;
Pearce, W;
McGranahan, N;
Dewhurst, SM;
Meniel, V;
... Vanhaesebroeck, B; + view all
(2017)
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling.
Nature Communications
, 8
, Article 1773. 10.1038/s41467-017-02002-4.
|
Bi, WL;
Hosny, A;
Schabath, MB;
Giger, ML;
Birkbak, NJ;
Mehrtash, A;
Allison, T;
... Aerts, HJWL; + view all
(2019)
Artificial intelligence in cancer imaging: Clinical challenges and applications.
CA: A Cancer Journal for Clinicians
, 69
(2)
pp. 127-157.
10.3322/caac.21552.
|
Biswas, Dhruva;
Liu, Yun-Hsin;
Herrero, Javier;
Wu, Yin;
Moore, David A;
Karasaki, Takahiro;
Grigoriadis, Kristiana;
... Swanton, Charles; + view all
(2025)
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
adenocarcinoma.
Nature Cancer
, 6
pp. 86-101.
10.1038/s43018-024-00883-1.
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
Black, James RM;
Bartha, Gabor;
Abbott, Charles W;
Boyle, Sean M;
Karasaki, Takahiro;
Li, Bailiang;
Chen, Rui;
... Swanton, Charles; + view all
(2025)
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
Nature Medicine
, 31
pp. 70-76.
10.1038/s41591-024-03216-y.
|
Black, JRM;
Bailey, C;
Przewrocka, J;
Dijkstra, KK;
Swanton, C;
(2020)
COVID-19: the case for health-care worker screening to prevent hospital transmission.
The Lancet
, 395
(10234)
pp. 1418-1420.
10.1016/S0140-6736(20)30917-X.
|
Blagih, J;
Zani, F;
Chakravarty, P;
Hennequart, M;
Pilley, S;
Hobor, S;
Hock, AK;
... Vousden, KH; + view all
(2020)
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.
Cell Reports
, 30
(2)
481-496.e6.
10.1016/j.celrep.2019.12.028.
|
Blakely, CM;
Watkins, TBK;
Wu, W;
Gini, B;
Chabon, JJ;
McCoach, CE;
McGranahan, N;
... Bivona, TG; + view all
(2017)
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.
Nature Genetics
, 49
(12)
pp. 1693-1704.
10.1038/ng.3990.
|
Boire, Adrienne;
Burke, Katy;
Cox, Thomas R;
Guise, Theresa;
Jamal-Hanjani, Mariam;
Janowitz, Tobias;
Kaplan, Rosandra;
... Sahai, Erik; + view all
(2024)
Why do patients with cancer die?
Nature Reviews Cancer
, 24
(8)
pp. 578-589.
10.1038/s41568-024-00708-4.
|
Bortolomeazzi, M;
Keddar, MR;
Montorsi, L;
Acha-Sagredo, A;
Benedetti, L;
Temelkovski, D;
Choi, S;
... Ciccarelli, FD; + view all
(2021)
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.
Gastroenterology
10.1053/j.gastro.2021.06.064.
(In press).
|
Boumelha, Jesse;
de Carné Trécesson, Sophie;
Law, Emily K;
Romero-Clavijo, Pablo;
Coelho, Matthew;
Ng, Kevin;
Mugarza, Edurne;
... Downward, Julian; + view all
(2022)
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.
Cancer Research
, 82
(19)
pp. 3435-3448.
10.1158/0008-5472.CAN-22-0325.
|
Buck, M;
Poirier, E;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... The Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay [version 1; peer review: 1 approved with reservations].
Wellcome Open Research
, 6
(9)
10.12688/wellcomeopenres.16517.1.
|
Buck, MD;
Poirier, EZ;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay.
Wellcome Open Research
, 6
, Article 9. 10.12688/wellcomeopenres.16517.2.
|
Budczies, J;
Allgäuer, M;
Litchfield, K;
Rempel, E;
Christopoulos, P;
Kazdal, D;
Endris, V;
... Stenzinger, A; + view all
(2019)
Optimizing panel-based tumor mutational burden (TMB) measurement.
Annals of Oncology
, 30
(9)
pp. 1496-1506.
10.1093/annonc/mdz205.
|
Burrell, Rebecca A;
McClelland, Sarah E;
Endesfelder, David;
Groth, Petra;
Weller, Marie-Christine;
Shaikh, Nadeem;
Domingo, Enric;
... Swanton, Charles; + view all
(2013)
Replication stress links structural and numerical cancer chromosomal instability.
Nature
, 494
(7438)
pp. 492-496.
10.1038/nature11935.
|
Cai, H;
Chew, SK;
Li, C;
Tsai, MK;
Andrejka, L;
Murray, CW;
Hughes, NW;
... Winslow, MM; + view all
(2021)
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
Cancer Discovery
, 11
(7)
pp. 1754-1773.
10.1158/2159-8290.CD-20-1325.
|
Caswell, Deborah R;
Gui, Philippe;
Mayekar, Manasi K;
Law, Emily K;
Pich, Oriol;
Bailey, Chris;
Boumelha, Jesse;
... Swanton, Charles; + view all
(2023)
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Nature Genetics
10.1038/s41588-023-01592-8.
(In press).
|
Caswell, DR;
Swanton, C;
(2017)
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
[Review].
BMC Medicine
, 15
, Article 133. 10.1186/s12916-017-0900-y.
|
Cerone, Maria Antonietta;
Mills, Tara C;
Sharpe, Rowena;
McBride, David;
MacDonald, Moira;
MacMahon, Suzanne;
Mugalaasi, Hood;
... SMP2, consortium; + view all
(2023)
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
British Journal of Cancer
10.1038/s41416-022-02107-8.
(In press).
|
Chafe, Shawn C;
Zhai, Kui;
Aghaei, Nikoo;
Miletic, Petar;
Huang, Zhi;
Brown, Kevin R;
Mobilio, Daniel;
... Singh, Sheila K; + view all
(2025)
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.
Science Translational Medicine
, 17
(805)
10.1126/scitranslmed.adu2459.
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
Chu, Yanshuo;
Dai, Enyu;
Li, Yating;
Han, Guangchun;
Pei, Guangsheng;
Ingram, Davis R;
Thakkar, Krupa;
... Wang, Linghua; + view all
(2023)
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
Nature Medicine
, 29
(6)
pp. 1550-1562.
10.1038/s41591-023-02371-y.
|
Conforti, F;
Pala, L;
Pagan, E;
Bagnardi, V;
De Pas, T;
Queirolo, P;
Pennacchioli, E;
... Giaccone, G; + view all
(2021)
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion.
Clinical Cancer Research
, 27
(15)
pp. 4311-4324.
10.1158/1078-0432.CCR-21-0136.
|
Crockford, A;
Zalmas, LP;
Grönroos, E;
Dewhurst, SM;
McGranahan, N;
Cuomo, ME;
Encheva, V;
... Swanton, C; + view all
(2017)
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.
Annals of Oncology
, 28
(1)
pp. 149-156.
10.1093/annonc/mdw612.
|
DeGregori, James;
Pharoah, Paul;
Sasieni, Peter;
Swanton, Charles;
(2020)
Cancer Screening, Surrogates of Survival, and the Soma.
Cancer Cell
, 38
(4)
pp. 433-437.
10.1016/j.ccell.2020.09.003.
|
Dentro, SC;
Leshchiner, I;
Haase, K;
Tarabichi, M;
Wintersinger, J;
Deshwar, AG;
Yu, K;
... PCAWG Evolution and Heterogeneity Working Group and the PCAWG Co, .; + view all
(2021)
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Cell
, 184
(8)
pp. 2239-2254.
10.1016/j.cell.2021.03.009.
|
Dietzen, Michelle;
Zhai, Haoran;
Lucas, Olivia;
Pich, Oriol;
Barrington, Christopher;
Lu, Wei-Ting;
Ward, Sophia;
... Kanu, Nnennaya; + view all
(2024)
Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution.
Nature Communications
, 15
(1)
, Article 6039. 10.1038/s41467-024-50107-4.
|
Domingues, PH;
Nanduri, LSY;
Seget, K;
Venkateswaran, SV;
Agorku, D;
Vigano, C;
von Schubert, C;
... Hardt, O; + view all
(2017)
Cellular Prion Protein PrPC and Ecto-5′-Nucleotidase Are Markers of the Cellular Stress Response to Aneuploidy.
Cancer Research
, 77
(11)
pp. 2914-2926.
10.1158/0008-5472.CAN-16-3052.
|
Dowgier, G;
Hobbs, A;
Greenwood, D;
Shawe-Taylor, M;
Stevenson-Leggett, P;
Bazire, J;
Penn, R;
... Wu, MY; + view all
(2025)
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Vaccine
, 54
, Article 126960. 10.1016/j.vaccine.2025.126960.
|
Endesfelder, David;
Burrell, Rebecca A;
Kanu, Nnennaya;
McGranahan, Nicholas;
Howell, Mike;
Parker, Peter J;
Downward, Julian;
... Kschischo, Maik; + view all
(2014)
Chromosomal instability selects gene copy number variants
encoding core regulators of proliferation in ER+ breast cancer.
Cancer Research
, 74
(17)
pp. 4853-4863.
10.1158/0008-5472.CAN-13-2664.
|
Enfield, Katey SS;
Colliver, Emma;
Lee, Claudia SY;
Magness, Alastair;
Moore, David A;
Sivakumar, Monica;
Grigoriadis, Kristiana;
... Angelova, Mihaela; + view all
(2024)
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.
Cancer Discovery
, 14
(1)
pp. 1-30.
10.1158/2159-8290.CD-23-1380.
|
Fendler, A;
Au, L;
Shepherd, STC;
Byrne, F;
Cerrone, M;
Boos, LA;
Rzeniewicz, K;
... Wilkinson, RJ; + view all
(2021)
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00275-9.
(In press).
|
Fendler, A;
Shepherd, STC;
Au, L;
Wilkinson, KA;
Wu, M;
Byrne, F;
Cerrone, M;
... Turajlic, S; + view all
(2021)
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00274-w.
(In press).
|
Frankell, Alexander M;
Dietzen, Michelle;
Al Bakir, Maise;
Lim, Emilia L;
Karasaki, Takahiro;
Ward, Sophia;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2024)
The evolution of lung cancer and impact of subclonal selection in TRACERx (vol 616, pg 525, 2023).
[Corrigendum].
Nature
, 631
, Article E15. 10.1038/s41586-024-07738-w.
|
Frankell, AM;
Dietzen, M;
Al Bakir, M;
Lim, EL;
Karasaki, T;
Ward, S;
Veeriah, S;
... Gilbert, K; + view all
(2023)
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
, 616
pp. 525-533.
10.1038/s41586-023-05783-5.
|
Fu, X;
Zhao, Y;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Bates, PA; + view all
(2021)
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.
Nature Ecology & Evolution
10.1038/s41559-021-01586-x.
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
Ghorani, E;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Lynch, M;
Peggs, KS;
Swanton, C;
(2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Annals of Oncology
, 29
(1)
pp. 271-279.
10.1093/annonc/mdx687.
|
Goh, G;
Schmid, R;
Guiver, K;
Arpornwirat, W;
Chitapanarux, I;
Ganju, V;
Im, SA;
... Swanton, C; + view all
(2016)
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
PLOS Med
, 13
(12)
, Article e1002136. 10.1371/journal.pmed.1002136.
|
Greenwood, Hannah E;
Barber, Abigail R;
Edwards, Richard S;
Tyrrell, Will E;
George, Madeleine E;
Dos Santos, Sofia N;
Baark, Friedrich;
... Witney, Timothy H; + view all
(2024)
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography.
Nature Communications
, 15
, Article 10484. 10.1038/s41467-024-54852-4.
|
Grey, William;
Rio-Machin, Ana;
Casado, Pedro;
Grönroos, Eva;
Ali, Sara;
Miettinen, Juho J;
Bewicke-Copley, Findlay;
... Bonnet, Dominique; + view all
(2022)
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.
Science Translational Medicine
, 14
(650)
, Article eabn3248. 10.1126/scitranslmed.abn3248.
|
Grigoriadis, Kristiana;
Huebner, Ariana;
Bunkum, Abigail;
Colliver, Emma;
Frankell, Alexander M;
Hill, Mark S;
Thol, Kerstin;
... McGranahan, Nicholas; + view all
(2024)
CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction.
Nature Protocols
, 19
pp. 159-183.
10.1038/s41596-023-00913-9.
|
Hainsworth, JD;
Meric-Bernstam, F;
Swanton, C;
Hurwitz, H;
Spigel, DR;
Sweeney, C;
Burris, H;
... Kurzrock, R; + view all
(2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.
Journal of Clinical Oncology
, 36
(6)
pp. 536-544.
10.1200/JCO.2017.75.3780.
|
Han, G;
Yang, G;
Hao, D;
Lu, Y;
Thein, K;
Simpson, BS;
Chen, J;
... Wang, L; + view all
(2021)
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.
Nature Communications
, 12
, Article 5606. 10.1038/s41467-021-25894-9.
|
Hasan, AM Mahedi;
Cremaschi, Paolo;
Wetterskog, Daniel;
Jayaram, Anuradha;
Wong, Stephen Q;
Williams, Scott;
Pasam, Anupama;
... Attard, Gerhardt; + view all
(2023)
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Nature Communications
, 14
, Article 4823. 10.1038/s41467-023-40315-9.
|
Hellewell, J;
Russell, TW;
SAFER Investigators and Field Study Team, ,;
Crick COVID-19 Consortium, ,;
CMMID COVID-19 working group, ,;
Beale, R;
Kelly, G;
... Kucharski, AJ; + view all
(2021)
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections.
BMC Medicine
, 19
(1)
, Article 106. 10.1186/s12916-021-01982-x.
|
Hellmann, MD;
Nathanson, T;
Rizvi, H;
Creelan, BC;
Sanchez-Vega, F;
Ahuja, A;
Ni, A;
... Wolchok, JD; + view all
(2018)
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Cancer Cell
, 33
(5)
843-852.e4.
10.1016/j.ccell.2018.03.018.
|
Hessey, Sonya;
Fessas, Petros;
Zaccaria, Simone;
Jamal-Hanjani, Mariam;
Swanton, Charles;
(2023)
Insights into the metastatic cascade through research autopsies.
Trends Cancer
10.1016/j.trecan.2023.03.002.
|
Hiley, CT;
Le Quesne, J;
Santis, G;
Sharpe, R;
De Castro, DG;
Middleton, G;
Swanton, C;
(2016)
Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.
The Lancet
, 388
(10048)
pp. 1002-1011.
10.1016/S0140-6736(16)31340-X.
|
Hill, William;
Weeden, Clare E;
Swanton, Charles;
(2024)
Tumor Promoters and Opportunities for Molecular Cancer Prevention.
Cancer Discovery
, 14
(7)
pp. 1154-1160.
10.1158/2159-8290.CD-24-0128.
|
Hobor, S;
Al Bakir, M;
Hiley, CT;
Skrzypski, M;
Frankell, AM;
Bakker, B;
Watkins, TBK;
... Clipson, A; + view all
(2024)
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Nature Communications
, 15
, Article 4871. 10.1038/s41467-024-47606-9.
|
Houlihan, CF;
Vora, N;
Byrne, T;
Lewer, D;
Kelly, G;
Heaney, J;
Gandhi, S;
... SAFER Investigators; + view all
(2020)
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
The Lancet
, 396
(10246)
e6-e7.
10.1016/S0140-6736(20)31484-7.
|
Hsieh, JJ;
Purdue, MP;
Signoretti, S;
Swanton, C;
Albiges, L;
Schmidinger, M;
Heng, DY;
... Ficarra, V; + view all
(2017)
Renal cell carcinoma.
Nature Reviews Disease Primers
, 3
, Article 17009. 10.1038/nrdp.2017.9.
|
Hudeček, J;
Voorwerk, L;
van Seijen, M;
Nederlof, I;
de Maaker, M;
van den Berg, J;
van de Vijver, KK;
... Peale, F; + view all
(2020)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
npj Breast Cancer
, 6
, Article 15. 10.1038/s41523-020-0155-1.
|
Hung, King L;
Luebeck, Jens;
Dehkordi, Siavash R;
Colón, Caterina I;
Li, Rui;
Wong, Ivy Tsz-Lo;
Coruh, Ceyda;
... Chang, Howard Y; + view all
(2022)
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH.
Nature Genetics
10.1038/s41588-022-01190-0.
(In press).
|
Huntley, C;
Torr, B;
Sud, A;
Rowlands, CF;
Way, R;
Snape, K;
Hanson, H;
... Turnbull, C; + view all
(2023)
Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
The Lancet Oncology
, 24
(6)
pp. 658-668.
10.1016/S1470-2045(23)00156-0.
|
Hynds, Robert E;
Huebner, Ariana;
Pearce, David R;
Hil, Mark S;
Akarca, Ayse U;
Moore, David A;
Ward, Sophia;
... Swanton, Charles; + view all
(2024)
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Nature Communications
, 15
, Article 4653. 10.1038/s41467-024-47547-3.
|
Hynds, RE;
Ben Aissa, A;
Gowers, KHC;
Watkins, TBK;
Bosshard-Carter, L;
Rowan, AJ;
Veeriah, S;
... Janes, SM; + view all
(2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
International Journal of Cancer
, 143
(1)
pp. 160-166.
10.1002/ijc.31383.
|
Hynds, RE;
Frese, KK;
Pearce, DR;
Grönroos, E;
Dive, C;
Swanton, C;
(2021)
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.
Open Biology
, 11
(1)
, Article 200247. 10.1098/rsob.200247.
|
Jamal-Hanjani, M;
Thanopoulou, E;
Peggs, KS;
Quezada, SA;
Swanton, C;
(2013)
Tumour heterogeneity and immune-modulation.
Curr Opin Pharmacol
, 13
(4)
497 - 503.
10.1016/j.coph.2013.04.006.
|
Jamal-Hanjani, M;
Wilson, GA;
McGranahan, N;
Birkbak, NJ;
Watkins, TBK;
Veeriah, S;
Shafi, S;
... Swanton, C; + view all
(2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer.
New England Journal of Medicine
, 376
(22)
pp. 2109-2121.
10.1056/NEJMoa1616288.
|
Jamshidi, A;
Liu, MC;
Klein, EA;
Venn, O;
Hubbell, E;
Beausang, JF;
Gross, S;
... Swanton, C; + view all
(2022)
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Cancer Cell
, 40
(12)
pp. 1537-1549.
10.1016/j.ccell.2022.10.022.
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
Kanu, N;
Groenroos, E;
Martinez, P;
Burrell, RA;
Goh, X Yi;
Bartkova, J;
Maya-Mendoza, A;
... Swanton, C; + view all
(2015)
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.
Oncogene
, 34
(46)
pp. 5699-5708.
10.1038/onc.2015.24.
|
Kanu, N;
Zhang, T;
Burrell, RA;
Chakraborty, A;
Cronshaw, J;
DaCosta, C;
Grönroos, E;
... Behrens, A; + view all
(2015)
RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress.
Oncogene
, 35
(30)
pp. 4009-4019.
10.1038/onc.2015.427.
|
Kanu, Nnennaya;
Lu, Wei-Ting;
Swanton, Charles;
Bartek, Jiri;
(2025)
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling.
Nature Cell Biology
, 27
(1)
pp. 154-168.
10.1038/s41556-024-01558-w.
|
Kanu, N;
Cerone, MA;
Goh, G;
Zalmas, L-P;
Bartkova, J;
Dietzen, M;
McGranahan, N;
... Swanton, C; + view all
(2016)
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Genome Biology
, 17
, Article 185. 10.1186/s13059-016-1042-9.
|
Kaufmann, Tom L;
Petkovic, Marina;
Watkins, Thomas BK;
Colliver, Emma C;
Laskina, Sofya;
Thapa, Nisha;
Minussi, Darlan C;
... Schwarz, Roland F; + view all
(2022)
MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution.
Genome Biology volume
, 23
, Article 241. 10.1186/s13059-022-02794-9.
|
Kim, YJ;
Sheu, KM;
Tsoi, J;
Abril-Rodriguez, G;
Medina, E;
Grasso, CS;
Torrejon, DY;
... Ribas, A; + view all
(2021)
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy.
The Journal of Clinical Investigation
, 131
(12)
, Article e145859. 10.1172/JCI145859.
|
Klein, EA;
Richards, D;
Cohn, A;
Tummala, M;
Lapham, R;
Cosgrove, D;
Chung, G;
... Liu, MC; + view all
(2021)
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Annals of Oncology
10.1016/j.annonc.2021.05.806.
(In press).
|
Kos, Z;
Roblin, E;
Kim, RS;
Michiels, S;
Gallas, BD;
Chen, W;
van de Vijver, KK;
... International Immuno-Oncology Biomarker Working Group; + view all
(2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ Breast Cancer
, 6
, Article 17. 10.1038/s41523-020-0156-0.
|
Kurzrock, R;
Bowles, DW;
Kang, H;
Meric-Bernstam, F;
Hainsworth, J;
Spigel, DR;
Bose, R;
... Swanton, C; + view all
(2020)
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Annals of Oncology
, 31
(3)
pp. 412-421.
10.1016/j.annonc.2019.11.018.
|
Lange, Joshua T;
Rose, John C;
Chen, Celine Y;
Pichugin, Yuriy;
Xie, Liangqi;
Tang, Jun;
Hung, King L;
... Mischel, Paul S; + view all
(2022)
The evolutionary dynamics of extrachromosomal DNA in human cancers.
Nature Genetics
10.1038/s41588-022-01177-x.
(In press).
|
Leung, Michelle M;
Swanton, Charles;
Mcgranahan, Nicholas;
(2025)
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.
Nature Reviews Genetics
, 26
pp. 494-505.
10.1038/s41576-025-00825-2.
|
Li, J;
Duran, MA;
Dhanota, N;
Chatila, WK;
Bettigole, SE;
Kwon, J;
Sriram, RK;
... Bakhoum, SF; + view all
(2021)
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.
Cancer Discovery
, 11
(5)
pp. 1212-1227.
10.1158/2159-8290.CD-20-0387.
|
Linch, M;
Goh, G;
Hiley, C;
Shanmugabavan, Y;
McGranahan, N;
Rowan, A;
Wong, YNS;
... Swanton, C; + view all
(2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Annals of Oncology
, 28
(10)
pp. 2472-2480.
10.1093/annonc/mdx355.
|
Litchfield, K;
Reading, JL;
Lim, EL;
Xu, H;
Liu, P;
Al-Bakir, M;
Wong, YNS;
... Swanton, C; + view all
(2020)
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature Communications
, 11
, Article 3800. 10.1038/s41467-020-17526-5.
|
Litchfield, K;
Reading, JL;
Puttick, C;
Thakkar, K;
Abbosh, C;
Bentham, R;
Watkins, TBK;
... Swanton, C; + view all
(2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Cell
, 184
(3)
596-614.e14.
10.1016/j.cell.2021.01.002.
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
Litchfield, K;
Turajlic, S;
Swanton, C;
(2017)
The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released.
Cancer Discovery
, 7
(8)
pp. 796-798.
10.1158/2159-8290.CD-17-0604.
|
Liu, MC;
Oxnard, GR;
Klein, EA;
Swanton, C;
Seiden, MV;
CCGA Consortium, .;
(2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Annals of Oncology
, 31
(6)
pp. 745-759.
10.1016/j.annonc.2020.02.011.
|
Loennstedt, Ingrid M;
Caramia, Franco;
Li, Jason;
Fumagalli, Debora;
Salgado, Roberto;
Rowan, Andrew;
Salm, Max;
... Speed, Terence P; + view all
(2014)
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data.
Genome Biology
, 15
(9)
, Article 470. 10.1186/s13059-014-0470-7.
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
Lopez-Garcia, C;
Sansregret, L;
Domingo, E;
McGranahan, N;
Hobor, S;
Birkbak, NJ;
Horswell, S;
... Swanton, C; + view all
(2017)
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer.
Cancer Cell
, 31
(1)
pp. 79-93.
10.1016/j.ccell.2016.11.001.
|
Loveday, C;
Litchfield, K;
Proszek, PZ;
Cornish, AJ;
Santo, F;
Levy, M;
Macintyre, G;
... Turnbull, C; + view all
(2020)
Genomic landscape of platinum resistant and sensitive testicular cancers.
Nature Communications
, 11
, Article 2189. 10.1038/s41467-020-15768-x.
|
Lu, L;
Teixeira, VH;
Yuan, Z;
Graham, TA;
Endesfelder, D;
Kolluri, K;
Al-Juffali, N;
... Janes, SM; + view all
(2013)
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.
J Pathol
, 229
(4)
608 - 620.
10.1002/path.4148.
|
Lucas, Olivia;
Ward, Sophia;
Zaidi, Rija;
Bunkum, Abigail;
Frankell, Alexander M;
Moore, David A;
Hill, Mark S;
... Zaccaria, Simone; + view all
(2024)
Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER.
Nature Genetics
10.1038/s41588-024-01989-z.
(In press).
|
Mackay, HL;
Moore, D;
Hall, C;
Birkbak, NJ;
Jamal-Hanjani, M;
Karim, SA;
Phatak, VM;
... Muller, PAJ; + view all
(2018)
Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nature Communications
, 9
, Article 3070. 10.1038/s41467-018-05368-1.
|
Maiani, E;
Milletti, G;
Nazio, F;
Holdgaard, SG;
Bartkova, J;
Rizza, S;
Cianfanelli, V;
... Cecconi, F; + view all
(2021)
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.
Nature
, 592
(7856)
pp. 799-803.
10.1038/s41586-021-03422-5.
|
Maley, CC;
Aktipis, A;
Graham, TA;
Sottoriva, A;
Boddy, AM;
Janiszewska, M;
Silva, AS;
... Shibata, D; + view all
(2017)
Classifying the evolutionary and ecological features of neoplasms.
Nature Reviews Cancer
, 17
(10)
pp. 605-619.
10.1038/nrc.2017.69.
|
Martins, Filipe Correia;
Couturier, Dominique-Laurent;
De Santiago, Ines;
Sauer, Carolin Margarethe;
Vias, Maria;
Angelova, Mihaela;
Sanders, Deborah;
... Brenton, James D; + view all
(2022)
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.
Nature Communications
, 13
(1)
, Article 6360. 10.1038/s41467-022-33870-0.
|
Mateo, J;
Chakravarty, D;
Dienstmann, R;
Jezdic, S;
Gonzalez-Perez, A;
Lopez-Bigas, N;
Ng, CKY;
... Pusztai, L; + view all
(2018)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Annals of Oncology
, 29
(9)
pp. 1895-1902.
10.1093/annonc/mdy263.
|
McGranahan, N;
Rosenthal, R;
Hiley, CT;
Rowan, AJ;
Watkins, TBK;
Wilson, GA;
Birkbak, NJ;
... Swanton, C; + view all
(2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Cell
10.1016/j.cell.2017.10.001.
(In press).
|
McGranahan, N;
Swanton, C;
(2019)
Neoantigen quality, not quantity.
Science Translational Medicine
, 11
(506)
, Article eaax7918. 10.1126/scitranslmed.aax7918.
|
McGranahan, N;
Swanton, C;
(2017)
Cancer Evolution Constrained by the Immune Microenvironment.
CELL
, 170
(5)
pp. 825-827.
10.1016/j.cell.2017.08.012.
|
McGranahan, N;
Swanton, C;
(2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
Cell
, 168
(4)
pp. 613-628.
10.1016/j.cell.2017.01.018.
|
Mears, HV;
Young, GR;
Sanderson, T;
Harvey, R;
Barrett-Rodger, J;
Penn, R;
Cowton, V;
... Bauer, DLV; + view all
(2025)
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
PLoS Biology
, 23
(1)
, Article e3002982. 10.1371/journal.pbio.3002982.
|
Meric-Bernstam, F;
Hurwitz, H;
Raghav, KPS;
McWilliams, RR;
Fakih, M;
VanderWalde, A;
Swanton, C;
... Hainsworth, J; + view all
(2019)
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncology
, 20
(4)
pp. 518-530.
10.1016/S1470-2045(18)30904-5.
|
Middleton, G;
Fletcher, P;
Popat, S;
Savage, J;
Summers, Y;
Greystoke, A;
Gilligan, D;
... Billingham, L; + view all
(2020)
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature
, 583
(7818)
pp. 807-812.
10.1038/s41586-020-2481-8.
|
Miller, RE;
Brown, NE;
Speirs, A;
Shaw, HM;
Adeleke, S;
Gougis, P;
Bennett, P;
... Kristeleit, RS; + view all
(2016)
The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials.
Annals of Oncology
, 27
(Suppl 6)
pp. 114-135.
10.1093/annonc/mdw368.44.
|
Mitchell, TJ;
Turajlic, S;
Rowan, A;
Nicol, D;
Farmery, JHR;
O'Brien, T;
Martincorena, I;
... Campbell, PJ; + view all
(2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Cell
, 173
(3)
, Article e17. 10.1016/j.cell.2018.02.020.
|
Molnar, Janos;
Poti, Adam;
Pipek, Orsolya;
Krzystanek, Marcin;
Kanu, Nnennaya;
Swanton, Charles;
Tusnady, Gabor E;
... Szuets, David; + view all
(2014)
The Genome of the Chicken DT40 Bursal Lymphoma Cell Line.
G3-GENES GENOMES GENETICS
, 4
(11)
pp. 2231-2240.
10.1534/g3.114.013482.
|
Montgomery, HE;
Haines, A;
Marlow, N;
Pearson, G;
Mythen, MG;
Grocott, MPW;
Swanton, C;
(2017)
The future of UK healthcare: problems and potential solutions to a system in crisis.
[Review].
Annals of Oncology
, 28
(8)
pp. 1751-1755.
10.1093/annonc/mdx136.
|
Moore, DA;
Kushnir, M;
Mak, G;
Winter, H;
Curiel, T;
Voskoboynik, M;
Moschetta, M;
... Arkenau, HT; + view all
(2019)
Prospective analysis of 895 patients on a UK Genomics Review Board.
ESMO Open
, 4
(2)
, Article e000469. 10.1136/esmoopen-2018-000469.
|
Morales Torres, C;
Wu, MY;
Hobor, S;
Wainwright, EN;
Martin, MJ;
Patel, H;
Grey, W;
... Scaffidi, P; + view all
(2020)
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis.
Nature Communications
, 11
(1)
, Article 1792. 10.1038/s41467-020-15615-z.
|
Morrissy, AS;
Cavalli, FMG;
Remke, M;
Ramaswamy, V;
Shih, DJH;
Holgado, BL;
Farooq, H;
... Taylor, MD; + view all
(2017)
Spatial heterogeneity in medulloblastoma.
Nature Genetics
, 49
(5)
pp. 780-788.
10.1038/ng.3838.
|
Munkhbaatar, E;
Dietzen, M;
Agrawal, D;
Anton, M;
Jesinghaus, M;
Boxberg, M;
Pfarr, N;
... Jost, PJ; + view all
(2020)
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Nature Communications
, 11
(1)
, Article 4527. 10.1038/s41467-020-18372-1.
|
Naxerova, K;
Reiter, JG;
Brachtel, E;
Lennerz, JK;
van de Wetering, M;
Rowan, A;
Cai, T;
... Jain, RK; + view all
(2017)
Origins of lymphatic and distant metastases in human colorectal cancer.
Science
, 357
(6346)
pp. 55-60.
10.1126/science.aai8515.
|
Neal, RD;
Johnson, P;
Clarke, CA;
Hamilton, SA;
Zhang, N;
Kumar, H;
Swanton, C;
(2022)
Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.
Cancers
, 14
(19)
, Article 4818. 10.3390/cancers14194818.
|
Ng, Kevin W;
Boumelha, Jesse;
Enfield, Katey SS;
Almagro, Jorge;
Cha, Hongui;
Pich, Oriol;
Karasaki, Takahiro;
... Kassiotis, George; + view all
(2023)
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Nature
10.1038/s41586-023-05771-9.
(In press).
|
Ng, Kevin W;
Faulkner, Nikhil;
Finsterbusch, Katja;
Wu, Mary;
Harvey, Ruth;
Hussain, Saira;
Greco, Maria;
... Kassiotis, George; + view all
(2022)
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies.
Science Translational Medicine
, 14
(655)
, Article eabn3715. 10.1126/scitranslmed.abn3715.
|
Ng, KW;
Faulkner, N;
Cornish, GH;
Rosa, A;
Harvey, R;
Hussain, S;
Ulferts, R;
... Kassiotis, G; + view all
(2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science
, Article eabe1107. 10.1126/science.abe1107.
(In press).
|
Noorani, Imran;
Luebeck, Jens;
Rowan, Andrew;
Gronroos, Eva;
Barbe, Vittorio;
Fabian, Mark;
Nicoll, James;
... Swanton, Charles; + view all
(2024)
Oncogenic extrachromosomal DNA identification using whole-genome sequencing from formalin-fixed glioblastomas.
Annals of Oncology
, 35
(6)
pp. 570-573.
10.1016/j.annonc.2024.03.008.
|
Pan, Xiaoxi;
AbdulJabbar, Khalid;
Coelho-Lima, Jose;
Grapa, Anca-Ioana;
Zhang, Hanyun;
Cheung, Alvin Ho Kwan;
Baena, Juvenal;
... Moore, David A; + view all
(2024)
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.
Nature Cancer
10.1038/s43018-023-00694-w.
|
|
Pandya, Tej;
Cao, Yin;
Smith-Byrne, Karl;
Swanton, Charles;
(2025)
Mechanism-Enhanced Population Science: Strengthening Population Studies Through Mechanistic Insights.
Annals of Oncology
10.1016/j.annonc.2025.08.006.
(In press).
|
Passaro, Antonio;
Al Bakir, Maise;
Hamilton, Emily G;
Diehn, Maximilian;
André, Fabrice;
Roy-Chowdhuri, Sinchita;
Mountzios, Giannis;
... Peters, Solange; + view all
(2024)
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell
, 187
(7)
pp. 1617-1635.
10.1016/j.cell.2024.02.041.
|
Pennycuick, A;
Teixeira, VH;
AbdulJabbar, K;
Raza, SEA;
Lund, T;
Akarca, AU;
Rosenthal, R;
... Janes, SM; + view all
(2020)
Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer.
Cancer Discovery
, 10
(10)
pp. 1489-1499.
10.1158/2159-8290.CD-19-1366.
|
Pich, Oriol;
Bailey, Chris;
Watkins, Thomas BK;
Zaccaria, Simone;
Jamal-Hanjani, Mariam;
Swanton, Charles;
(2022)
The translational challenges of precision oncology.
Cancer Cell
, 40
(5)
pp. 458-478.
10.1016/j.ccell.2022.04.002.
|
Przewrocka, J;
Rowan, A;
Rosenthal, R;
Kanu, N;
Swanton, C;
(2020)
Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting.
Annals of Oncology
, 31
(9)
pp. 1270-1273.
10.1016/j.annonc.2020.04.480.
|
Puttick, Clare;
Jones, Thomas P;
Leung, Michelle M;
Galvez-Cancino, Felipe;
Liu, Jiali;
Varas-Godoy, Manuel;
Rowan, Andrew;
... Mcgranahan, Nicholas; + view all
(2024)
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Nature Genetics
, 56
(10)
pp. 2121-2131.
10.1038/s41588-024-01883-8.
|
Rane, Jayant K;
Frankell, Alexander M;
Weeden, Clare E;
Swanton, Charles;
(2023)
Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception Strategies.
Cancer Prevention Research
, 16
(7)
pp. 369-378.
10.1158/1940-6207.CAPR-22-0469.
|
Reading, James L;
Caswell, Deborah R;
Swanton, Charles;
(2023)
Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumors.
Nature Genetics
, 55
(10)
pp. 1610-1612.
10.1038/s41588-023-01492-x.
|
Reading, JL;
Gálvez-Cancino, F;
Swanton, RC;
Lladser, A;
Peggs, K;
Quezada, S;
(2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity.
Immunological Reviews
, 283
(1)
pp. 194-212.
10.1111/imr.12657.
|
Rodríguez-Martínez, M;
Boissiére, T;
Gonzalez, MN;
Litchfield, K;
Mitter, R;
Walker, J;
Kjœr, S;
... Svejstrup, JQ; + view all
(2020)
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver.
Cell
, 181
(6)
1395-1405.e11.
10.1016/j.cell.2020.04.014.
|
Rosenthal, R;
Cadieux, EL;
Salgado, R;
Bakir, MA;
Moore, DA;
Hiley, CT;
Lund, T;
... TRACERx consortium; + view all
(2019)
Neoantigen-directed immune escape in lung cancer evolution.
Nature
10.1038/s41586-019-1032-7.
(In press).
|
Rosenthal, R;
McGranahan, N;
Herrero, J;
Swanton, C;
(2017)
Deciphering Genetic Intratumor Heterogeneity and Its Impact on Cancer Evolution.
Annual Review of Cancer Biology
, 1
pp. 223-240.
10.1146/annurev-cancerbio-042516-011348.
|
Rosenthal, R;
McGranahan, N;
Herrero, J;
Taylor, BS;
Swanton, C;
(2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
Genome Biol
, 17
(1)
p. 31.
10.1186/s13059-016-0893-4.
|
Rosenthal, R;
Swanton, C;
McGranahan, N;
(2021)
Understanding the impact of immune-mediated selection on lung cancer evolution.
British Journal of Cancer
, 124
(10)
pp. 1615-1617.
10.1038/s41416-020-01232-6.
|
Sansregret, L;
Patterson, JO;
Dewhurst, S;
Lopez-Garcia, C;
Koch, A;
McGranahan, N;
Chao, WCH;
... Swanton, C; + view all
(2017)
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability.
Cancer Discovery
, 7
(2)
pp. 218-233.
10.1158/2159-8290.CD-16-0645.
|
Sansregret, L;
Swanton, C;
(2017)
The Role of Aneuploidy in Cancer Evolution.
Cold Spring Harbor Perspectives in Medicine
, 7
(1)
, Article a028373. 10.1101/cshperspect.a028373.
|
Sansregret, L;
Vanhaesebroeck, B;
Swanton, C;
(2018)
Determinants and clinical implications of chromosomal instability in cancer.
Nature Reviews Clinical Oncology
, 15
(3)
pp. 139-150.
10.1038/nrclinonc.2017.198.
|
Sasieni, P;
Smittenaar, R;
Hubbell, E;
Broggio, J;
Neal, RD;
Swanton, C;
(2023)
Modelled mortality benefits of multi-cancer early detection screening in England.
British Journal of Cancer
, 129
pp. 72-80.
10.1038/s41416-023-02243-9.
|
|
Sasieni, P;
Swanton, C;
Neal, R;
(2025)
Advanced cancer: a robust surrogate of cancer mortality in early detection trials?
Annals of Oncology
10.1016/j.annonc.2025.03.001.
(In press).
|
Sasieni, Peter;
Swanton, Charles;
Neal, Richard D;
(2025)
The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issues.
Journal of the National Cancer Institute
, Article djaf218. 10.1093/jnci/djaf218.
(In press).
|
Savas, Peter;
Teo, Zhi Ling;
Lefevre, Christophe;
Flensburg, Christoffer;
Caramia, Franco;
Alsop, Kathryn;
Mansour, Mariam;
... Loi, Sherene; + view all
(2017)
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
[Corrigendum].
PLoS Med
, 14
(4)
e1002302.
10.1371/journal.pmed.1002302.
|
Savas, P;
Teo, ZL;
Lefevre, C;
Flensburg, C;
Caramia, F;
Alsop, K;
Mansour, M;
... Loi, S; + view all
(2016)
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Medicine
, 13
(12)
, Article e1002204. 10.1371/journal.pmed.1002204.
|
Scelo, G;
Hofmann, JN;
Banks, RE;
Bigot, P;
Bhatt, RS;
Cancel-Tassin, G;
Chew, SK;
... Chanock, SJ; + view all
(2016)
International cancer seminars: a focus on kidney cancer.
Annals of Oncology
, 27
(8)
pp. 1382-1385.
10.1093/annonc/mdw186.
|
Shao, SH;
Allen, B;
Clement, J;
Chung, G;
Gao, J;
Hubbell, E;
Liu, MC;
... Tummala, M; + view all
(2022)
Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options.
Tumori
10.1177/03008916221133136.
(In press).
|
Shawe-Taylor, Marianne;
Greenwood, David;
Hobbs, Agnieszka;
Dowgier, Giulia;
Penn, Rebecca;
Sanderson, Theo;
Stevenson-Leggett, Phoebe;
... Wall, Emma C; + view all
(2024)
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
The Lancet
, 403
(10432)
pp. 1133-1136.
10.1016/S0140-6736(24)00316-7.
|
Spain, Lavinia;
Coulton, Alexander;
Lobon, Irene;
Rowan, Andrew;
Schnidrig, Desiree;
Shepherd, Scott TC;
Shum, Benjamin;
... Turajlic, Samra; + view all
(2023)
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Cancer Discovery
, 13
(6)
pp. 1364-1385.
10.1158/2159-8290.CD-22-1427.
|
Sud, A;
Jones, M;
Broggio, J;
Loveday, C;
Torr, B;
Garrett, A;
Nicol, DL;
... Turnbull, C; + view all
(2020)
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
Annals of Oncology
10.1016/j.annonc.2020.05.009.
(In press).
|
Sud, A;
Torr, B;
Jones, ME;
Broggio, J;
Scott, S;
Loveday, C;
Garrett, A;
... Turnbull, C; + view all
(2020)
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
The Lancet Oncology
, 21
(8)
pp. 1035-1044.
10.1016/S1470-2045(20)30392-2.
|
Swanton, C;
Bernard, E;
Abbosh, C;
André, F;
Auwerx, J;
Balmain, A;
Bar-Sagi, D;
... Hanahan, D; + view all
(2024)
Embracing cancer complexity: Hallmarks of systemic disease.
Cell
, 187
(7)
pp. 1589-1616.
10.1016/j.cell.2024.02.009.
|
Swanton, C;
Beck, SA;
(2014)
Epigenetic noise fuels cancer evolution.
Cancer Cell
, 26
(6)
pp. 775-776.
10.1016/j.ccell.2014.11.003.
|
Swanton, C;
Govindan, R;
(2016)
Clinical Implications of Genomic Discoveries in Lung Cancer.
New England Journal of Medicine
, 374
(19)
pp. 1864-1873.
10.1056/NEJMra1504688.
|
Sweeney, Christopher J;
Hainsworth, John D;
Bose, Ron;
Burris, Howard A;
Kurzrock, Razelle;
Swanton, Charles;
Friedman, Claire F;
... Meric-Bernstam, Funda; + view all
(2024)
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors.
Journal of Clinical Oncology
, 42
(3)
pp. 258-265.
10.1200/JCO.22.02636.
|
Szikriszt, B;
Póti, Á;
Németh, E;
Kanu, N;
Swanton, C;
Szüts, D;
(2021)
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms.
Mutagenesis
, 36
(1)
pp. 75-86.
10.1093/mutage/geab005.
|
Szikriszt, B;
Poti, A;
Pipek, O;
Krzystanek, M;
Kanu, N;
Molnar, J;
Ribli, D;
... Szuts, D; + view all
(2016)
A comprehensive survey of the mutagenic impact of common cancer cytotoxics.
Genome Biology
, 17
, Article 99. 10.1186/s13059-016-0963-7.
|
Tang, WHW;
Yimer, H;
Tummala, M;
Shao, S;
Chung, G;
Clement, J;
Chu, BC;
... Roberts, LR; + view all
(2023)
Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.
Preventive Medicine
, 167
, Article 107384. 10.1016/j.ypmed.2022.107384.
|
Teixeira, VH;
Pipinikas, CP;
Pennycuick, A;
Lee-Six, H;
Chandrasekharan, D;
Beane, J;
Morris, TJ;
... Janes, SM; + view all
(2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.
Nature Medicine
, 25
pp. 517-525.
10.1038/s41591-018-0323-0.
|
Trebeschi, S;
Drago, SG;
Birkbak, NJ;
Kurilova, I;
Calin, AM;
Pizzi, AD;
Lalezari, F;
... Aerts, HJWL; + view all
(2019)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
Annals of Oncology
, 30
(6)
pp. 998-1004.
10.1093/annonc/mdz108.
|
Turajlic, S;
Litchfield, K;
Xu, H;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Wong, YNS;
... Swanton, C; + view all
(2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
The Lancet Oncology
, 18
(8)
pp. 1009-1021.
10.1016/S1470-2045(17)30516-8.
|
Turajlic, S;
Swanton, C;
Boshoff, C;
(2018)
Kidney cancer: The next decade.
Journal of Experimental Medicine
, 215
(9)
10.1084/jem.20181617.
|
Turajlic, S;
Xu, H;
Litchfield, K;
Rowan, A;
Chambers, T;
Lopez, JI;
Nicol, D;
... Swanton, C; + view all
(2018)
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell
, 173
(3)
581-594.e12.
10.1016/j.cell.2018.03.057.
|
Turajlic, S;
Xu, H;
Litchfield, K;
Rowan, A;
Horswell, S;
Chambers, T;
O'Brien, T;
... TRACERx Renal Consortium, .; + view all
(2018)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Cell
, 173
(3)
595-610.e11.
10.1016/j.cell.2018.03.043.
|
Uddin, I;
Joshi, K;
Oakes, T;
Heather, JM;
Swanton, C;
TRACERx consortium, .;
Chain, B;
(2019)
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
Cancer Immunosurveillance: Methods and Protocols
pp. 15-42.
10.1007/978-1-4939-8885-3_2.
|
Usaite, Ieva;
Biswas, Dhruva;
Dijkstra, Krijn;
Watkins, Thomas Bk;
Pich, Oriol;
Puttick, Clare;
Angelova, Mihaela;
... Kanu, Nnennaya; + view all
(2023)
Quantifying the impact of immunotherapy on RNA dynamics in cancer.
Journal for ImmunoTherapy of Cancer
, 11
(11)
, Article e007870. 10.1136/jitc-2023-007870.
|
van Maldegem, F;
Valand, K;
Cole, M;
Patel, H;
Angelova, M;
Rana, S;
Colliver, E;
... Downward, J; + view all
(2021)
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.
Nature Communications
, 12
(1)
, Article 5906. 10.1038/s41467-021-26214-x.
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
Vargas, FA;
Furness, AJS;
Solomon, I;
Joshi, K;
Mekkaoui, L;
Lesko, MH;
Rota, EM;
... Quezada, SA; + view all
(2017)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Immunity
, 46
(4)
pp. 577-586.
10.1016/j.immuni.2017.03.013.
|
Vendramin, R;
Litchfield, K;
Swanton, C;
(2021)
Cancer evolution: Darwin and beyond.
EMBO Journal
, Article e108389. 10.15252/embj.2021108389.
|
Venkatesan, S;
Angelova, M;
Bartkova, J;
Bakhoum, SF;
Bartek, J;
Kanu, N;
Swanton, C;
(2021)
APOBEC3 as a driver of genetic intratumor heterogeneity.
Molecular and Cellular Oncology
10.1080/23723556.2021.2014734.
(In press).
|
Venkatesan, S;
Angelova, M;
Puttick, C;
Zhai, H;
Caswell, DR;
Lu, W-T;
Dietzen, M;
... Consortium, T; + view all
(2021)
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.
Cancer Discovery
, 11
(10)
pp. 2456-2473.
10.1158/2159-8290.CD-20-0725.
|
Venkatesan, S;
Rosenthal, R;
Kanu, N;
McGranahan, N;
Bartek, J;
Quezada, SA;
Hare, J;
... Swanton, C; + view all
(2018)
APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Annals of Oncology
, 29
(3)
pp. 563-572.
10.1093/annonc/mdy003.
|
Virassamy, B;
Caramia, F;
Savas, P;
Sant, S;
Wang, J;
Christo, SN;
Byrne, A;
... Loi, S; + view all
(2023)
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.
Cancer Cell
, 41
(3)
585-601.e8.
10.1016/j.ccell.2023.01.004.
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DL; + view all
(2021)
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
The Lancet
10.1016/S0140-6736(21)01462-8.
(In press).
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DLV; + view all
(2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
The Lancet
10.1016/s0140-6736(21)01290-3.
(In press).
|
Watkins, Thomas BK;
Colliver, Emma C;
Huska, Matthew R;
Kaufmann, Tom L;
Lim, Emilia L;
Duncan, Cody B;
Haase, Kerstin;
... Schwarz, Roland F; + view all
(2023)
Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity.
PLoS Computational Biology
, 19
(10)
, Article e1011379. 10.1371/journal.pcbi.1011379.
|
Watkins, TBK;
Lim, EL;
Petkovic, M;
Elizalde, S;
Birkbak, NJ;
Wilson, GA;
Moore, DA;
... Swanton, C; + view all
(2020)
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
, 587
pp. 126-132.
10.1038/s41586-020-2698-6.
|
Weeden, CE;
Gayevskiy, V;
Marceaux, C;
Batey, D;
Tan, T;
Yokote, K;
Ribera, NT;
... Asselin-Labat, ML; + view all
(2023)
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer.
Cancer Cell
, 41
(5)
837-852.e6.
10.1016/j.ccell.2023.03.019.
|
Wolf, Y;
Bartok, O;
Patkar, S;
Bar Eli, G;
Cohen, S;
Litchfield, K;
Levy, R;
... Samuels, Y; + view all
(2019)
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Cell
, 179
(1)
219-235.e21.
10.1016/j.cell.2019.08.032.
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
Wong, YNS;
Joshi, K;
Pule, M;
Peggs, KS;
Swanton, C;
Quezada, SA;
Linch, M;
(2017)
Evolving adoptive cellular therapies in urological malignancies.
Lancet Oncology
, 18
(6)
E341-E353.
10.1016/S1470-2045(17)30327-3.
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Plate, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2019)
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nature Communications
, 10
, Article 6. 10.1038/s41467-018-07858-8.
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Platé, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2020)
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
[Corrigendum].
Nature Communications
, 11
, Article 4680. 10.1038/s41467-020-18621-3.
|
Wu, Mary Y;
Carr, Edward J;
Harvey, Ruth;
Mears, Harriet V;
Kjaer, Svend;
Townsley, Hermaleigh;
Hobbs, Agnieszka;
... Bauer, David LV; + view all
(2022)
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
The Lancet
, 400
(10369)
pp. 2193-2196.
10.1016/s0140-6736(22)01938-9.
|
Wu, MY;
Shepherd, STC;
Fendler, A;
Carr, EJ;
Au, L;
Harvey, R;
Dowgier, G;
... Turajlic, S; + view all
(2023)
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
, 41
(5)
pp. 821-823.
10.1016/j.ccell.2023.04.005.
|
Wu, Yin;
Biswas, Dhruva;
Usaite, Ieva;
Angelova, Mihaela;
Boeing, Stefan;
Karasaki, Takahiro;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2022)
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer.
Nature Cancer
, 3
pp. 696-709.
10.1038/s43018-022-00376-z.
|
Wu, Y;
Biswas, D;
Swanton, C;
(2021)
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response.
Seminars in Cancer Biology
10.1016/j.semcancer.2021.02.013.
(In press).
|
Yousefi, Maryam;
Boross, Gábor;
Weiss, Carly;
Murray, Christopher W;
Hebert, Jess D;
Cai, Hongchen;
Ashkin, Emily L;
... Winslow, Monte M; + view all
(2022)
Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.
Cancer Research
, 82
(8)
pp. 1589-1602.
10.1158/0008-5472.CAN-22-0059.
|
Zamborszky, J;
Szikriszt, B;
Gervai, JZ;
Pipek, O;
Poti, A;
Krzystanek, M;
Ribli, D;
... Szuets, D; + view all
(2016)
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.
Oncogene
, 36
(6)
pp. 746-755.
10.1038/onc.2016.243.
|
Zhang, Hanyun;
AbdulJabbar, Khalid;
Moore, David A;
Akarca, Ayse;
Enfield, Katey SS;
Jamal-Hanjani, Mariam;
Raza, Shan E Ahmed;
... Yuan, Yinyin; + view all
(2023)
Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.
Cancer Research
, 83
(9)
pp. 1410-1425.
10.1158/0008-5472.CAN-22-2589.
|
Zhang, M;
Luo, J-L;
Sun, Q;
Harber, J;
Dawson, AG;
Nakas, A;
Busacca, S;
... Fennell, DA; + view all
(2021)
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nature Communications
, 12
(1)
, Article 1751. 10.1038/s41467-021-21798-w.
|
Zhao, Y;
Fu, X;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Litchfield, K; + view all
(2021)
Selection of metastasis competent subclones in the tumour interior.
Nature Ecology & Evolution
, 5
pp. 1033-1045.
10.1038/s41559-021-01456-6.
|
Proceedings paper
Raza, SEA;
AbdulJabbar, K;
Jamal-Hanjani, M;
Veeriah, S;
Le Quesne, J;
Swanton, C;
Yuan, Y;
(2019)
Deconvolving Convolutional Neural Network for Cell Detection.
In:
2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019).
(pp. pp. 891-894).
IEEE: Venice, Italy,.
|
Working / discussion paper
Fendler, Annika;
Au, Lewis;
Shepherd, Scott TC;
Byrne, Fiona;
Cerrone, Maddalena;
Boos, Laura Amanda;
Rzeniewicz, Karolina;
... Turajlic, Samra; + view all
(2021)
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Research Square: Durham, NC, USA.
|
Thesis
Crockford, AJ;
(2016)
Deciphering tetraploid tolerance.
Doctoral thesis , UCL (University College London).
|
Dewhurst, SM;
(2015)
Whole genome doubling propagates chromosomal instability and accelerates cancer genome evolution.
Doctoral thesis , UCL (University College London).
|